Showing results (121-130 of 154) with videos related to
Sort By:
Pageof 16
Expert Opinion on Pharmacotherapy|June 7, 2018
Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progressionYukio Hosomi, Chiharu Tanai, Kiyotaka Yoh, et al.ESMO Open|October 12, 2017
Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational studyYasushi Goto, Chiharu Tanai, Kiyotaka Yoh, et al.Nature Genetics|July 17, 2012
A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese populationKouya Shiraishi, Hideo Kunitoh, Yataro Daigo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study GroupKaoru Kubota, Koshiro Watanabe, Hideo Kunitoh, et al.Clinical Pharmacology and Therapeutics|August 8, 2006
Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancerYukiko Nakajima, Takashi Yoshitani, Hiromi Fukushima-Uesaka, et al.Cancer Chemotherapy and Pharmacology|November 10, 2007
Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patientsKimie Sai, Yoshiro Saito, Hiromi Fukushima-Uesaka, et al.American Journal of Clinical Oncology|March 10, 2018
Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Research Group (TORG) 0809Seiji Niho, Norihiko Ikeda, Hiroshi Michimae, et al.JAMA Oncology|May 15, 2020
Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 TrialShingo Miyamoto, Koichi Azuma, Hidenobu Ishii, et al.Carcinogenesis|June 16, 2006
Association of polymorphisms in the MTH1 gene with small cell lung carcinoma riskTakashi Kohno, Tokuki Sakiyama, Hideo Kunitoh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancerHideharu Kimura, Kazuo Kasahara, Kazuhiko Shibata, et al.Pageof 16